In the media
- 19 September, 2018
BrainsWay’s TMS Device Cleared for OCD Treatment
The Food and Drug Administration has recently cleared Deep TMS treatment to treat those suffering from Obsession Compulsive Disorder (OCD), as an adjunct therapy to medication and psychotherapy. BrainsWay
Read More 
12 September, 2018Dr. Oscar Morales Interviewed by Health Professional Radio
Dr. Oscar Morales, psychiatrist and Senior Medical Advisor at Achieve TMS East, is interviewed by Health Professional Radio on the use of BrainsWay Deep TMS for treatment of depression and OCD. The
Read More
5 September, 2018ADHD Patient Participates in TMS Clinical Trial
A young woman suffering from ADHD didn’t like the idea of medicating herself, so subsequently enrolled in a clinical trial for Deep TMS treatment. The procedure is meant to be an alternative to
Read More
29 August, 2018HPR Treatment Centers Expands Use of Deep TMS Throughout the US
HPR Treatment Centers, from its beginnings in Hackensack, NJ, has expanded from coast to coast, and is leveraging BrainsWay Deep TMS technology to treat its MDD patients. MyVeronaNJ profiles a new
Read More
25 June, 2018Jersey Matters Features MDD Patient Helped by Integrative Behavioral Care & BrainsWay
With only one out of every three patients using antidepressants achieve remission, its no secret why more and more patients suffering from depression seek TMS treatment. Jersey Matters interviews
Read More
9 April, 2018Health Care and Hospitals Opening Up to TMS
Not only have private practices been experiencing success with TMS, but hospitals have been as well according to Carlos Rueda, the MD chairman of psychiatry for St. Joseph’s Behavioral Health
Read More
13 December, 2016BrainsWay Raises Close to 9 Million to Treat Depression
After years of developing the device, BrainsWay has invested $8.5 million to strengthen the Brain disorder treatment business. Now, the company is set to launch its device consisting of a helmet lined
Read More